Multi-system disorders of glycosphingolipid and ganglioside metabolism - Wikidata - awgldk - TriplyDB

Multi-system disorders of glycosphingolipid and ganglioside metabolism

Multi-system disorders of glycosphingolipid and ganglioside metabolism

http://www.wikidata.org/entity/Q33902037

about

Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration Lysosomal storage diseases and the heat shock response: convergences and therapeutic opportunities Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in double-positive thymocytes Assessment of Membrane Fluidity Fluctuations during Cellular Development Reveals Time and Cell Type Specificity Evaluation of the photooxidation of galactosyl- and lactosylceramide by electrospray ionization mass spectrometry.Gangliosides and ceramides change in a mouse model of blast induced traumatic brain injury Comprehensive gene expression analysis of human embryonic stem cells during differentiation into neural cells Decreased amyloid-β pathologies by intracerebral loading of glycosphingolipid-enriched exosomes in Alzheimer model mice Neurologic abnormalities in mouse models of the lysosomal storage disorders mucolipidosis II and mucolipidosis III γ.Heat shock protein-based therapy as a potential candidate for treating the sphingolipidoses.Manipulating ionic strength to improve single cell electrophoretic separations Filipin recognizes both GM1 and cholesterol in GM1 gangliosidosis mouse brain.Variation in 12 porcine genes involved in the carbohydrate moiety assembly of glycosphingolipids does not account for differential binding of F4 Escherichia coli and their fimbriae.Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.Ganglioside biochemistry Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model.Arylsulfatase A deficiency causes seminolipid accumulation and a lysosomal storage disorder in Sertoli cells Systems toxicology approaches enable mechanistic comparison of spontaneous and cigarette smoke-related lung tumor development in the A/J mouse model.Thiogalactopyranosides are resistant to hydrolysis by α-galactosidases.Quantitative GSL-glycome analysis of human whole serum based on an EGCase digestion and glycoblotting method.Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury.Ceramide sphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neurons.Neuraminidase-1 contributes significantly to the degradation of neuronal B-series gangliosides but not to the bypass of the catabolic block in Tay-Sachs mouse models.Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency.Role of glycosphingolipids in dendritic cell-mediated HIV-1 trans-infection.Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant mice.Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia.Missense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe disease Lipidomics of glycosphingolipids.Inhibition of GM3 synthase attenuates neuropathology of Niemann-Pick disease Type C. by affecting sphingolipid metabolism.Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.Glycosphingolipids in signaling and development: from liposomes to model organisms.Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases.The glycosphingolipid hydrolases in the central nervous system.Human genetic disorders of sphingolipid biosynthesis.Reference Materials: Significance, General Requirements, and Demand.Perspective on innovative therapies for globoid cell leukodystrophy.RNAi-based biosynthetic pathway screens to identify in vivo functions of non-nucleic acid-based metabolites such as lipids Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases.

P2860

Q26995291-12066B51-2C84-45FB-92BB-355F4F519D44 Q27004531-DC475FA9-1FD4-477C-8726-C36A6B4F63D3 Q28584907-38A781CB-3294-4F74-9301-2C06D6A99A09 Q30378783-74CAE080-A1C4-4C91-9884-9A362198F652 Q30857220-4835DBEC-C345-4E23-A2A5-9DCD2FAA4ECD Q33457686-77F372A9-AF3D-4956-B86E-C072D75C3AAC Q33987997-5AB5A41F-5628-4B0A-9186-817CEFC50A86 Q34107323-C3B62768-7A27-4A6B-8BEC-BCDD527D124C Q34338364-634925E8-BD20-47EB-A82D-97AFCC2801E4 Q34539778-3212DA1E-4AD8-45F5-BA69-4794AF2FCB2D Q34691295-0722E746-A8F4-449D-BD33-1F239179BD26 Q35067305-6630EEB7-E8ED-465E-95D2-BFAE717F4211 Q35296427-27CB0EAA-86A8-4C70-B75B-828F9C2F1A78 Q35324757-7CCCC46C-63A9-4B07-9446-1D0255913B21 Q35361488-4A81F47B-0991-4CA4-AECD-569964F522CC Q35536435-3CF8F9A6-2496-489D-9900-2D21A8CD4703 Q35561966-C78EC396-1FAF-4DBF-85E3-21CEBEECD9D1 Q35594350-F2ECA63B-4B60-4A8C-B953-F2C44F16AEAF Q35637350-B328D537-801C-4F21-944F-D1A61D3BB108 Q35792977-7319530C-C4EF-458B-B861-025DC8C1E5D1 Q35845455-B18F72A9-2933-4C73-AD19-E1431E108C7A Q36320314-2CC14A11-AF07-4E3C-956C-B55C1CCD48E1 Q36571614-DA05204A-E7E6-4B79-BF12-2A925C3EEFEF Q36809656-FB413B2F-B00E-4608-A443-246ACD595316 Q36940332-2878F7E4-B749-4AD1-9B73-43DD174B7F20 Q37003180-0E10FC12-0094-4F20-BA16-965AB5DEA436 Q37010397-C41D5D37-F588-4570-AE4A-003EABC6D644 Q37078839-F14F6C5B-199D-4420-B64C-23A2D72B0BC2 Q37512584-735A5836-C049-40A9-AD07-8B868B1AAEDC Q37604835-1070C1E4-DF30-457C-87D6-D8649833D799 Q37880734-9EF349A2-2D9E-40D9-A869-E248E6D9A658 Q37950975-A826C4DF-E7EF-4FE1-8D7B-EAC03BB0759D Q38027745-D461AA6A-AB24-4224-9A10-F7D35F505141 Q38166684-E0832EB9-B9EE-4C4E-92A6-7A499650CE4F Q38241672-4F12E90D-00E5-4368-84E8-6C997AC523F0 Q38515546-58542438-FBC5-46BC-9D29-A065B0C33073 Q38957277-311EEE7D-11DC-44C0-A8DA-2C833C4479AF Q41147236-2A9B550A-4A04-428A-88BE-72321AB7D254 Q41871999-27FFB445-76E6-41EF-BF1F-84CB33CC857F Q42288514-11402225-737D-413E-AD37-C08C6C369920

P2860

Multi-system disorders of glycosphingolipid and ganglioside metabolism

http://www.wikidata.org/entity/Q33902037

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Multi-system disorders of glycosphingolipid and ganglioside metabolism

@ast

Multi-system disorders of glycosphingolipid and ganglioside metabolism

@en

type

label

Multi-system disorders of glycosphingolipid and ganglioside metabolism

@ast

Multi-system disorders of glycosphingolipid and ganglioside metabolism

@en

prefLabel

Multi-system disorders of glycosphingolipid and ganglioside metabolism

@ast

Multi-system disorders of glycosphingolipid and ganglioside metabolism

@en

P1433

Q33902037-10F5DBC0-A81C-4F29-8F84-7E2CAB2592C7

P1476

Q33902037-EA28DCC9-2971-48AA-8D90-DDE34F78C82D

P2093

Q33902037-902F1B3D-E7ED-43B2-885F-55FC8D7E046F

Q33902037-CC7A4F8A-EE75-4537-AEC0-46C7EED0F3F4

Q33902037-D53ABD1B-1192-44C9-A648-8E907DF677AF

Q33902037-D857239F-2668-4879-8A81-9CDC2422FB8C

P2860

Q33902037-00F4659B-25F1-458D-AD25-DECB842040A7

Q33902037-04B34A51-35AC-4FF2-9C0C-960283E4346A

Q33902037-04C2BB9A-7A37-4DEF-9077-FDEF6171D027

Q33902037-050DF863-A6C9-4F9E-8F15-50415B60E86E

Q33902037-052874B5-A9C1-40BA-8C57-6C5638FBE7E3

Q33902037-0536202A-0A3A-4913-B440-C8F75242D84B

Q33902037-066C9E22-0728-4531-9AA3-80CD931C70F8

Q33902037-0699BFD5-A84B-44CB-862E-A02491EF2D1E

Q33902037-06A0A84B-AA67-4399-B151-F4379DD89284

Q33902037-083C5762-5C88-4B1B-B3E5-BAC4C9D1A543

P304

Q33902037-A4DC69AD-6B8C-4871-882B-E08392DD7D4F

P31

Q33902037-56A239E6-3591-4630-8627-1E73C84FFC42

P356

Q33902037-592EF9FB-D1C6-4697-90B3-AF0642D13FB9

P433

Q33902037-52228D10-7DA2-4317-AB3D-1DF2830F7891

P478

Q33902037-FB3E0230-0E3E-452E-8B32-B86FCC76E6B2

P577

Q33902037-451A5347-987D-424E-932C-550E8076CDF2

P698

Q33902037-70FD7DBA-60C6-4D17-AEE1-4EAD609A0C35

P932

Q33902037-2B72D38A-1787-4AD8-8EC8-D285D3F3EBED

P356

P1433

Journal of Lipid Research

P1476

Multi-system disorders of glycosphingolipid and ganglioside metabolism

@en

P2093

Gregory A Grabowski

http://www.w3.org/2001/XMLSchema#string

Sonya Barnes

http://www.w3.org/2001/XMLSchema#string

Ying Sun

http://www.w3.org/2001/XMLSchema#string

You-Hai Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression

Fabry disease: recent advances in pathology, diagnosis, treatment and monitoring

Hereditary sensory neuropathy type I

Identification of HE1 as the second gene of Niemann-Pick C disease

Association of alpha- and beta-subunits during the biosynthesis of beta-hexosaminidase in cultured human fibroblasts

Molecular machinery for non-vesicular trafficking of ceramide

NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes

MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine

Acid beta-glucosidase 1 counteracts p38delta-dependent induction of interleukin-6: possible role for ceramide as an anti-inflammatory lipid

Involvement of acid beta-glucosidase 1 in the salvage pathway of ceramide formation

P304

1643-1675

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.R003996

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20211931

http://www.w3.org/2001/XMLSchema#string

P932

2882741

http://www.w3.org/2001/XMLSchema#string